Financial

Elutia Awarded Cardiac Rhythm Management Devices Agreement with Premier, Inc.

SILVER SPRING, Md., Dec. 02, 2024 (GLOBE NEWSWIRE) — Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix products, announced it has been awarded a national group purchasing agreement for Cardiac Rhythm Management Devices with Premier, Inc. Effective November 15, 2024, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for the EluPro™ Antibiotic-Eluting BioEnvelope.

Segmed’s real-world imaging data solution to be integrated into Bayer platform to accelerate the development of AI-powered healthcare solutions

Segmed’s 100 million imaging studies will help power the new AI innovation platform from Bayer in Radiology, enabling organizations to build AI-powered healthcare solutions to benefit radiologists and patients. PALO ALTO, Calif., Dec. 2, 2024 /PRNewswire/ — Segmed today announced that it…

Viz.ai Collaborates with Microsoft to Advance AI-powered Clinical Workflows and Better Patient Care

Viz.ai One and Precision Imaging Network simplify healthcare organization access to a comprehensive collection of diagnostic imaging AI models and end-to-end care coordination November 27, 2024 08:00 AM Eastern Standard Time SAN FRANCISCO–(BUSINESS WIRE)–Viz.ai, a leader in AI-powered disease detection and intelligent care coordination, today announced a collaboration with Microsoft […]